External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.
- DOI
- 10.1136/gutjnl-2024-332648
- Published
- 2024 Nov 11
- Container
- Gut
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/gutjnl-2024-332648,
title = {External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.},
author = {Pierre N and Huynh-Thu VA and Baiwir D and Mazzucchelli G and Fléron M and Trzpiot L and Eppe G and De Pauw E and Laharie D and Satsangi J and Bossuyt P and Vuitton L and Vieujean S and Colombel JF and Meuwis MA and Louis E and GETAID and the SPARE-Biocycle research group},
year = {2024},
journal = {Gut},
doi = {10.1136/gutjnl-2024-332648},
url = {https://doi.org/10.1136/gutjnl-2024-332648}
}RIS
TY - JOUR TI - External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab. AU - Pierre N AU - Huynh-Thu VA AU - Baiwir D AU - Mazzucchelli G AU - Fléron M AU - Trzpiot L AU - Eppe G AU - De Pauw E AU - Laharie D AU - Satsangi J AU - Bossuyt P AU - Vuitton L AU - Vieujean S AU - Colombel JF AU - Meuwis MA AU - Louis E AU - GETAID and the SPARE-Biocycle research group PY - 2024 JO - Gut DO - 10.1136/gutjnl-2024-332648 UR - https://doi.org/10.1136/gutjnl-2024-332648 ER -
APA
N, P., VA, H., D, B., G, M., M, F., L, T., G, E., E, D. P., D, L., J, S., P, B., L, V., S, V., JF, C., MA, M., E, L., & group, G. A. T. S. R. (2024). External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.. Gut. https://doi.org/10.1136/gutjnl-2024-332648
Source records
- pubmed · retrieved 2026-09-26T00:23:41.967Z